HIDRADENITIS SUPPURATIVA
Clinical trials for HIDRADENITIS SUPPURATIVA explained in plain language.
Never miss a new study
Get alerted when new HIDRADENITIS SUPPURATIVA trials appear
Sign up with your email to follow new studies for HIDRADENITIS SUPPURATIVA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for painful skin condition: experimental drug LAD328 enters phase 2 trial
Disease control Not yet recruitingThis study tests an experimental drug called LAD328 against a placebo in 50 adults with moderate-to-severe hidradenitis suppurativa, a chronic skin condition causing painful lumps. The goal is to see if LAD328 can reduce the number of inflamed lesions and improve symptoms. Partic…
Matched conditions: HIDRADENITIS SUPPURATIVA
Phase: PHASE2 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated May 26, 2026 10:55 UTC
-
Skin drug may shield hearts in hidradenitis patients
Disease control Not yet recruitingThis study follows 34 adults with moderate-to-severe hidradenitis suppurativa (HS) who are taking secukinumab as part of their regular care. Researchers want to see if this treatment can slow or prevent the growth of plaque in the heart's arteries over 12 months. Participants wil…
Matched conditions: HIDRADENITIS SUPPURATIVA
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 10:46 UTC
-
Italian skin disease registry aims to map Real-World treatment patterns
Knowledge-focused Not yet recruitingThis study will look at existing medical records from 20,000 people aged 12 and older in Italy who have psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa. Researchers want to learn about the types of treatments patients receive, how their diseas…
Matched conditions: HIDRADENITIS SUPPURATIVA
Sponsor: Fondazione ISIDE • Aim: Knowledge-focused
Last updated May 18, 2026 12:09 UTC